34 results
P03-45 - Psychosocial Functioning of Schizophrenic Patients in Post-Acute Treatment with Long-Acting Injectable Risperidone in Ambulatory Care
-
- Journal:
- European Psychiatry / Volume 25 / Issue S1 / 2010
- Published online by Cambridge University Press:
- 17 April 2020, 25-E1155
-
- Article
-
- You have access
- Export citation
P03-46 - Long-Term Safety, Tolerability and Efficacy of Risperidone Long-Acting Injectable and Oral Atypical Antipsychotics in Schizophrenic Patients: Two Year Naturalistic Study
-
- Journal:
- European Psychiatry / Volume 25 / Issue S1 / 2010
- Published online by Cambridge University Press:
- 17 April 2020, 25-E1156
-
- Article
-
- You have access
- Export citation
PW01-178 - Effectiveness, Tolerability And Compliance Of Schizophrenic Patients Under Treatment With Oral Atypical Antipsychotics Or Long-Acting Injectable Risperidone In Daily Routine
-
- Journal:
- European Psychiatry / Volume 25 / Issue S1 / 2010
- Published online by Cambridge University Press:
- 17 April 2020, 25-E1585
-
- Article
-
- You have access
- Export citation
Palmitate de palipéridone chez des patients atteints de schizophrénie, non-aigus mais symptomatiques, après échec d’un traitement par aripiprazole
-
- Journal:
- European Psychiatry / Volume 29 / Issue S3 / November 2014
- Published online by Cambridge University Press:
- 17 April 2020, p. 658
-
- Article
-
- You have access
- HTML
- Export citation
P03-44 - Effectiveness of Long-Acting Injectable Risperidone in the Post-Acute Treatment of Schizophrenic Patients in Ambulatory Care
-
- Journal:
- European Psychiatry / Volume 25 / Issue S1 / 2010
- Published online by Cambridge University Press:
- 17 April 2020, 25-E1154
-
- Article
-
- You have access
- Export citation
P0321 - Changes in quality of life in ADHD-patients treated with extended-release Methylphenidate (OROS®-MPH) - results from an open-label naturalistic study
-
- Journal:
- European Psychiatry / Volume 23 / Issue S2 / April 2008
- Published online by Cambridge University Press:
- 16 April 2020, p. S394
-
- Article
-
- You have access
- Export citation
P0138 - Evaluating decision criteria for the choice of pharmacological long-term therapy in risperidone treated patients with schizophrenia
-
- Journal:
- European Psychiatry / Volume 23 / Issue S2 / April 2008
- Published online by Cambridge University Press:
- 16 April 2020, p. S121
-
- Article
-
- You have access
- Export citation
Amélioration fonctionnelle sous palmitate de paliperidone à doses flexibles chez des patients aigus ou non aigus atteints de schizophrénie, après échec d’un traitement par antipsychotiques oraux
-
- Journal:
- European Psychiatry / Volume 28 / Issue S2 / November 2013
- Published online by Cambridge University Press:
- 16 April 2020, p. 108
-
- Article
-
- You have access
- Export citation
Transition from immediate-release methylphenidate (ir-mph) to extended-release methylphenidate (OROS®-MPH) improves quality of life of patients with adhd -a naturalistic study
-
- Journal:
- European Psychiatry / Volume 22 / Issue S1 / March 2007
- Published online by Cambridge University Press:
- 16 April 2020, p. S253
-
- Article
-
- You have access
- Export citation
Long-term adherence and health outcomes study with risperdal consta and oral atypicals in the treatment of schizophrenia patients (interim-analysis RIS-SCH-4023)
-
- Journal:
- European Psychiatry / Volume 22 / Issue S1 / March 2007
- Published online by Cambridge University Press:
- 16 April 2020, pp. S109-S110
-
- Article
-
- You have access
- Export citation
Time to clinical stabilization and discharge from hospital treatment of patients with schizophrenia after conversion to long-acting risperidone (RIS-CONSTA), ris-siv-401
-
- Journal:
- European Psychiatry / Volume 22 / Issue S1 / March 2007
- Published online by Cambridge University Press:
- 16 April 2020, pp. S115-S116
-
- Article
-
- You have access
- Export citation
P0282 - Treatment with OROS®-Methylphenidate in adolescents is associated with an improvement in functioning and quality of life - A post-hoc analysis
-
- Journal:
- European Psychiatry / Volume 23 / Issue S2 / April 2008
- Published online by Cambridge University Press:
- 16 April 2020, p. S383
-
- Article
-
- You have access
- Export citation
P0320 - OROS®-MPH in adolescents with ADHD transitioning from Atomoxetine or ER-MPH (medikinet retard®) - a post-hoc analysis
-
- Journal:
- European Psychiatry / Volume 23 / Issue S2 / April 2008
- Published online by Cambridge University Press:
- 16 April 2020, p. S394
-
- Article
-
- You have access
- Export citation
Paliperidone Palmitate – Effect On Negative, Depression/anxiety, Patient Functioning and Extrapyramidal Symptoms in Non-acute Schizophrenia Patients Previously Unsuccessfully Treated with Oral Aripiprazole
-
- Journal:
- European Psychiatry / Volume 30 / Issue S1 / March 2015
- Published online by Cambridge University Press:
- 15 April 2020, p. 1
-
- Article
-
- You have access
- Export citation
EPA-1545 - Functional Outcomes with Once-monthly Paliperidone Palmitate in Acute and in Non-acute Patients with Schizophrenia Previously Unsuccessfully Treated with Oral Antipsychotics
-
- Journal:
- European Psychiatry / Volume 29 / Issue S1 / 2014
- Published online by Cambridge University Press:
- 15 April 2020, p. 1
-
- Article
-
- You have access
- Export citation
EPA-1550 - Paliperidone Palmitate in Acute Patients with Schizophrenia: Treatment Response, Safety and Tolerability ? a Prospective Flexible-dose Study in Patients Previously Unsuccessfully Treated with Oral Antipsychotics
-
- Journal:
- European Psychiatry / Volume 29 / Issue S1 / 2014
- Published online by Cambridge University Press:
- 15 April 2020, p. 1
-
- Article
-
- You have access
- Export citation
P-1243 - Psychiatrists' Perceptions of the Clinical Importance, Assessment and Management of Functioning: Results of the Emea Survey in Schizophrenia
-
- Journal:
- European Psychiatry / Volume 27 / Issue S1 / 2012
- Published online by Cambridge University Press:
- 15 April 2020, p. 1
-
- Article
-
- You have access
- Export citation
Effets du palmitate de palipéridone sur les symptômes négatifs, la dépression/anxiété, le fonctionnement et les symptômes extrapyramidaux chez des patients souffrant d’une schizophrénie non-aiguë, en échec du traitement par aripiprazole oral
-
- Journal:
- European Psychiatry / Volume 30 / Issue S2 / November 2015
- Published online by Cambridge University Press:
- 15 April 2020, p. S151
-
- Article
-
- You have access
- HTML
- Export citation
1100 – Safety, Tolerability And Treatment Response With Flexible Doses Of Paliperidone Palmitate In Patients With An Acute Exacerbation Of Schizophrenia
-
- Journal:
- European Psychiatry / Volume 28 / Issue S1 / 2013
- Published online by Cambridge University Press:
- 15 April 2020, 28-E494
-
- Article
-
- You have access
- Export citation
Tolerability, Safety and Treatment Response of Flexibly-dosed Paliperidone Palmitate in Patients Hospitalized for an Exacerbation of Schizophrenia
-
- Journal:
- European Psychiatry / Volume 30 / Issue S1 / March 2015
- Published online by Cambridge University Press:
- 15 April 2020, p. 1
-
- Article
-
- You have access
- Export citation